FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4375952579> ?p ?o ?g. }

• W4375952579 endingPage "114845" @default.
• W4375952579 startingPage "114845" @default.
• W4375952579 abstract "Chronic pain is an enormous public health concern, and its treatment is still an unmet medical need. Starting from data highlighting the promising effects of some nonsteroidal anti-inflammatory drugs in combination with gabapentin in pain treatment, we sought to combine ketoprofen lysine salt (KLS) and gabapentin to obtain an effective multimodal therapeutic approach for chronic pain. Using relevant in vitro models, we first demonstrated that KLS and gabapentin have supra-additive effects in modulating key pathways in neuropathic pain and gastric mucosal damage. To leverage these supra-additive effects, we then chemically combined the two drugs via co-crystallization to yield a new compound, a ternary drug-drug co-crystal of ketoprofen, lysine and gabapentin (KLS-GABA co-crystal). Physicochemical, biodistribution and pharmacokinetic studies showed that within the co-crystal, ketoprofen reaches an increased gastrointestinal solubility and permeability, as well as a higher systemic exposure in vivo compared to KLS alone or in combination with gabapentin, while both the constituent drugs have increased central nervous system permeation. These unique characteristics led to striking, synergistic anti-nociceptive and anti-inflammatory effects of KLS-GABA co-crystal, as well as significantly reduced spinal neuroinflammation, in translational inflammatory and neuropathic pain rat models, suggesting that the synergistic therapeutic effects of the constituent drugs are further boosted by the co-crystallization. Notably, while strengthening the therapeutic effects of ketoprofen, KLS-GABA co-crystal showed remarkable gastrointestinal tolerability in both inflammatory and chronic neuropathic pain rat models. In conclusion, these results allow us to propose KLS-GABA co-crystal as a new drug candidate with high potential clinical benefit–to–risk ratio for chronic pain treatment." @default.
• W4375952579 created "2023-05-10" @default.
• W4375952579 creator A5003973455 @default.
• W4375952579 creator A5006945546 @default.
• W4375952579 creator A5015083578 @default.
• W4375952579 creator A5017239376 @default.
• W4375952579 creator A5018779032 @default.
• W4375952579 creator A5023809729 @default.
• W4375952579 creator A5023917485 @default.
• W4375952579 creator A5031544551 @default.
• W4375952579 creator A5036176074 @default.
• W4375952579 creator A5037639252 @default.
• W4375952579 creator A5042464140 @default.
• W4375952579 creator A5043525120 @default.
• W4375952579 creator A5048533516 @default.
• W4375952579 creator A5049717032 @default.
• W4375952579 creator A5052387291 @default.
• W4375952579 creator A5052789598 @default.
• W4375952579 creator A5073398411 @default.
• W4375952579 creator A5082541243 @default.
• W4375952579 creator A5083871762 @default.
• W4375952579 creator A5089900400 @default.
• W4375952579 creator A5091092251 @default.
• W4375952579 creator A5092344485 @default.
• W4375952579 date "2023-07-01" @default.
• W4375952579 modified "2023-09-27" @default.
• W4375952579 title "Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory pain" @default.
• W4375952579 cites W1709837271 @default.
• W4375952579 cites W1946635685 @default.
• W4375952579 cites W1964714442 @default.
• W4375952579 cites W1965693537 @default.
• W4375952579 cites W1971128550 @default.
• W4375952579 cites W1971892118 @default.
• W4375952579 cites W1981855934 @default.
• W4375952579 cites W1998842001 @default.
• W4375952579 cites W2003005781 @default.
• W4375952579 cites W2004600568 @default.
• W4375952579 cites W2010845171 @default.
• W4375952579 cites W2018579572 @default.
• W4375952579 cites W2025443625 @default.
• W4375952579 cites W2032849716 @default.
• W4375952579 cites W2046296795 @default.
• W4375952579 cites W2056455715 @default.
• W4375952579 cites W2058020736 @default.
• W4375952579 cites W2065229769 @default.
• W4375952579 cites W2067777829 @default.
• W4375952579 cites W2069302399 @default.
• W4375952579 cites W2072044677 @default.
• W4375952579 cites W2074279346 @default.
• W4375952579 cites W2092749349 @default.
• W4375952579 cites W2092809367 @default.
• W4375952579 cites W2127014579 @default.
• W4375952579 cites W2151778206 @default.
• W4375952579 cites W2155674292 @default.
• W4375952579 cites W2170823871 @default.
• W4375952579 cites W2171872873 @default.
• W4375952579 cites W2172201406 @default.
• W4375952579 cites W2270927172 @default.
• W4375952579 cites W2323484645 @default.
• W4375952579 cites W2329559358 @default.
• W4375952579 cites W2515930184 @default.
• W4375952579 cites W2522559948 @default.
• W4375952579 cites W255808519 @default.
• W4375952579 cites W2588923483 @default.
• W4375952579 cites W2594837965 @default.
• W4375952579 cites W2600095482 @default.
• W4375952579 cites W2736209824 @default.
• W4375952579 cites W2786697307 @default.
• W4375952579 cites W2793778562 @default.
• W4375952579 cites W2801007386 @default.
• W4375952579 cites W2801293457 @default.
• W4375952579 cites W2804670096 @default.
• W4375952579 cites W2806393666 @default.
• W4375952579 cites W2809082012 @default.
• W4375952579 cites W2902359770 @default.
• W4375952579 cites W2972002726 @default.
• W4375952579 cites W3016339266 @default.
• W4375952579 cites W3041579170 @default.
• W4375952579 cites W3106669496 @default.
• W4375952579 cites W3111858460 @default.
• W4375952579 cites W3165837403 @default.
• W4375952579 cites W3182208140 @default.
• W4375952579 cites W3190046884 @default.
• W4375952579 cites W3206609908 @default.
• W4375952579 cites W3212973387 @default.
• W4375952579 cites W4212839682 @default.
• W4375952579 cites W4281491359 @default.
• W4375952579 cites W4283656470 @default.
• W4375952579 cites W4284991816 @default.
• W4375952579 doi "https://doi.org/10.1016/j.biopha.2023.114845" @default.
• W4375952579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37167730" @default.
• W4375952579 hasPublicationYear "2023" @default.
• W4375952579 type Work @default.
• W4375952579 citedByCount "0" @default.
• W4375952579 crossrefType "journal-article" @default.
• W4375952579 hasAuthorship W4375952579A5003973455 @default.
• W4375952579 hasAuthorship W4375952579A5006945546 @default.
• W4375952579 hasAuthorship W4375952579A5015083578 @default.

• next